4 free views remaining today
focal segmental glomerulosclerosis 9
ICD-10 Codes
Related ICD-10:
Description
Focal Segmental Glomerular Sclerosis (FSGS): A Rare Kidney Disease
FSGS is a rare type of kidney disease that affects the tiny filters in the kidneys, called glomeruli. The main job of these filters is to remove waste and excess fluids from the blood, which are then excreted as urine.
Characteristics of FSGS:
- Focal: Only some of the glomeruli are affected, not all of them.
- Segmental: Each involved glomerulus is only partially damaged, not completely.
- Sclerosis: The damaged glomeruli become scarred and unable to filter blood properly.
Prevalence of FSGS:
- Accounts for 40% of cases in adults and 20% in children who have nephrotic syndrome.
- One of the commonest causes of primary glomerulopathy in adults.
**Causes and Effects of FSGS
Signs and Symptoms
Symptoms of Focal Segmental Glomerulosclerosis (FSGS)
FSGS can cause a variety of symptoms, which may vary in severity and frequency from person to person. Some common signs and symptoms of FSGS include:
- Foamy urine: This is caused by large amounts of protein leaking into the urine.
- Low serum albumin: The loss of protein through the urine can lead to low levels of albumin in the blood.
- Weight gain: Fluid retention, also known as edema, can cause weight gain and swelling in various parts of the body.
These symptoms are often a result of the kidney's inability to filter waste from the blood properly, leading to an accumulation of fluid and protein in the urine. If left untreated, FSGS can progress to more severe complications, such as kidney failure.
References:
- [9] Symptoms of focal segmental glomerulosclerosis · Foamy urine caused by large amounts of protein · Low serum albumin due to loss of protein · Weight gain caused by ...
- [6] Symptoms · Foamy urine (from excess protein in the urine) · Poor appetite · Swelling, called generalized edema, from fluids held in the body · Weight gain ...
Additional Symptoms
- Foamy urine
- Low serum albumin
- weight gain
Diagnostic Tests
Diagnostic Tests for Focal Segmental Glomerulosclerosis (FSGS)
Diagnosing FSGS can be a bit challenging, but several tests can help confirm the condition. Here are some of the diagnostic tests used to diagnose FSGS:
- Kidney Biopsy: This is considered the most definitive test for diagnosing FSGS. A biopsy involves taking a small sample from the kidney using a needle, and examining it under a microscope for signs of scarring or damage.
- Blood Tests: Blood tests can help assess how well the kidneys are functioning and detect any abnormalities in blood chemistry that may indicate FSGS.
- Urine Tests: Urine tests can also be used to diagnose FSGS. These tests can detect the presence of protein, blood, or other substances in the urine that may indicate kidney damage.
- Molecular Genetic Testing: In some cases, molecular genetic testing can confirm a diagnosis of FSGS by detecting abnormal genes associated with the condition.
According to [9], molecular genetic testing can confirm a diagnosis of FSGS in certain cases. This test utilizes next-generation sequencing to detect single nucleotide, deletion-insertion, and copy number variants in 56 genes associated with focal segmental glomerulosclerosis.
Additionally, as mentioned in [10], FSGS is a frequently encountered cause of nephrotic syndrome, accounting for 40% of cases in adults and 20% in children. The diagnosis of FSGS can be made based on the presence of scarring or damage to some (not all) glomeruli, which are the tiny filters in the kidney.
It's worth noting that a combination of these tests may be used to diagnose FSGS, as mentioned in [5].
Treatment
Treatment Options for Focal Segmental Glomerulosclerosis (FSGS)
According to various medical sources, the treatment options for FSGS include:
- Medications: Depending on symptoms, medicines to treat FSGS might include:
- Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) to lower blood pressure and reduce protein in the urine [1].
- Corticosteroids as a first-line therapy for primary FSGS [7].
- Calcineurin inhibitors (CNIs) as an alternative treatment option [8].
Other Treatment Considerations
- **Dietary
Recommended Medications
- ACE inhibitors
- Corticosteroids
- Calcineurin inhibitors
- ARBs
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Focal Segmental Glomerulosclerosis (FSGS)
Focal segmental glomerulosclerosis (FSGS) is a disease characterized by segments of sclerosis in some glomeruli. However, the differential diagnosis of FSGS involves considering other conditions that may present with similar clinical and histological features.
Conditions to Consider:
- Minimal Change Disease: This condition can be difficult to distinguish from FSGS, especially when only a small biopsy sample is available.
- Membranous Nephropathy: This disease can also cause nephrotic syndrome and may present with similar histological findings as FSGS.
- Diabetic Nephropathy: In some cases, diabetic nephropathy can mimic the clinical presentation of FSGS.
Key Features to Distinguish:
- Glomerulomegaly: The presence of glomerulomegaly and interstitial fibrosis in a young patient may suggest FSGS.
- Extensive Foot Process Effacement: The absence of diagnostic segmental lesions, along with extensive foot process effacement, can also point towards FSGS.
Diagnostic Approach:
A biopsy is necessary to establish the diagnosis of FSGS and determine the subtype. Genetic screening of patients with steroid-resistant FSGS may also be helpful in identifying underlying causes.
Citations: * [9] - The lesion of FSGS can be classified into primary, secondary, genetic, and undetermined forms using a clinicopathologic approach. * [10] - In patients presenting with nephrotic syndrome, differentiating focal segmental glomerulosclerosis from other conditions requires careful consideration of clinical and histological features.
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0111134
- core#notation
- DOID:0111134
- oboInOwl#hasDbXref
- MIM:616220
- IAO_0000115
- A focal segmental glomerulosclerosis that has_material_basis_in an autosomal recessive mutation of the CRB2 gene on chromosome 9q33.3.
- rdf-schema#label
- focal segmental glomerulosclerosis 9
- oboInOwl#hasExactSynonym
- FSGS9
- rdf-schema#subClassOf
- t374750
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/N04.1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_5469
- owl#annotatedSource
- t375392
- 22-rdf-syntax-ns#first
- t4027335
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.